Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 12/20 | 0.79 |
| ▸ | MAOA | P21397 | 5/20 | 0.79 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.79 |
| ▸ | SDHA | P31040 | 2/20 | 0.79 |
| ▸ | LMNA | P02545 | 1/20 | 0.79 |
| ▸ | CALML3 | P27482 | 1/20 | 0.79 |
| ▸ | F10 | P00742 | 7/20 | 0.69 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14577584 | 0.96 | MAOB (0.74) | MAOBMAOAPTGS1SDHALMNA | |
| SCHEMBL15788709 | 0.94 | MAOB (0.75) | MAOBMAOAPTGS1SDHALMNA | |
| SCHEMBL14490007 | 0.93 | MAOB (0.78) | MAOBMAOAPTGS1SDHALMNA | |
| SCHEMBL18652708 | 0.93 | MAOB (0.74) | MAOBMAOAPTGS1SDHALMNA | |
| SCHEMBL14885370 | 0.91 | MAOB (0.72) | MAOBMAOAPTGS1SDHALMNA | |
| SCHEMBL8304664 | 0.91 | MAOB (0.80) | MAOBMAOAPTGS1SDHALMNA | |
| SCHEMBL8304658 | 0.91 | MAOB (0.80) | MAOBMAOAPTGS1SDHALMNA | |
| SCHEMBL7262380 | 0.90 | MAOB (0.79) | MAOBMAOAPTGS1SDHALMNA | |
| SCHEMBL7256761 | 0.90 | MAOB (0.79) | MAOBMAOAPTGS1SDHALMNA | |
| SCHEMBL14489967 | 0.90 | MAOB (0.79) | MAOBMAOAPTGS1SDHALMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7179794-B2 | Multivalent macrolide antibiotics | THERAVANCE, INC. (US) | 2007-02-20 | — | — | US | disclosed |
| US-7179794-B2 | Multivalent macrolide antibiotics | THERAVANCE, INC. (US) | 2007-02-20 | — | — | US | disclosed |